You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 1 | BMC Pregnancy and Childbirth

Figure 1

From: Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol

Figure 1

Study design and key assessments. Study design and data collection overview. AE = adverse event; BM = biomarker; HELLP = hemolysis, elevated liver enzymes and low platelets; IUGR = intrauterine growth restriction; PlGF = placental growth factor; SAE = serious adverse event; sFlt-1 = soluble fms-like-tyrosine kinase 1; SGA = small for gestational age. aLaboratory parameters tested include thrombocyte counts and serum levels of aspartate aminotransferase, lactate dehydrogenase, and creatinine.

Back to article page